# Steris plc

Type: Company (STE)

Source: GetYourBrief — https://getyourbrief.com/entity/steris-plc
Canonical HTML page: https://getyourbrief.com/entity/steris-plc

## Timeline

- **2026-08-14**: STE trading level — STERIS shares opened at $232.88, within a 52-week range of $195.14 to $269.44.
- **2026-06-02**: Director Breeden insider sale — STERIS director Richard C. Breeden sold 1,481 shares at an average price of $209.51, totaling $310,284.31 — a 3.66% reduction leaving 38,964 shares directly owned.
- **2026-06**: Q2 2026 new positions — Stoneridge Investment Partners initiated a new 4,497-share stake valued at $1,027,000. Elevation Wealth Partners raised its stake 1,130% to 123 shares ($26,000).
- **2026-03**: Q1 2026 institutional accumulation — Goldman Sachs lifted its position 32.3% to 242,732 shares ($55.0M). Jane Street increased 38.9% to 20,716 shares ($4.7M). Woodline Partners grew 40.0% to 8,300 shares ($1.88M). Jones Financial raised 46.1%. Empowered Funds added 16.1%. Geneos Wealth grew 416.0%. Western Wealth opened a new $25,000 stake.
- **2025-12**: Q4 2025 13F filings — Activest Wealth Management raised its STERIS stake 423.8% to 110 shares ($28,000), and Measured Wealth Private Client Group opened a new position valued at about $28,000.

## Recent coverage (3 stories, network-wide)

### STERIS Institutional Ownership Hits 94.69% on 32.3% Goldman Boost
2026-08-17 02:11:21 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A wave of institutional accumulation in STERIS plc — including a 32.3% Goldman Sachs position increase and a new $1.03 million Stoneridge stake in Q2 2026 — signals confidence in the medical equipment provider's infection-prevention franchise. With institutions now holding 94.69% of shares and the company maintaining a 0.23 debt-to-equity ratio, STERIS appears positioned to absorb hospital capital-expenditure cycles. A modest June insider sale by director Richard C. Breeden at $209.51 is a minor contrarian signal in an otherwise bullish institutional pattern.
Full story: https://gethealthbrief.com/story/steris-institutional-ownership-infection-prevention-demand

### Goldman Sachs Ups STERIS 32.3% as Institutions Own 94.69%
2026-08-17 02:11:06 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2

STERIS plc's latest 13F disclosures show a broad institutional accumulation wave: Goldman Sachs raised its stake 32.3% to 242,732 shares ($55M) in Q1, and Stoneridge Investment Partners opened a new $1.03M position in Q2. With 94.69% of the float owned by institutions and a director selling $310K of stock in June, the signals are mixed. Conservative leverage (debt-to-equity 0.23) and a 1.35 quick ratio support the long case.
Full story: https://getfinancebrief.com/story/steris-13f-accumulation-goldman-institutional-ownership

### EPA Relaxes Ethylene Oxide Emission Standards for Medical Sterilizers
2026-03-13 21:25:14 · Sector: bio · Sentiment: Negative · Impact: 7/10 · Sources: 3

The Environmental Protection Agency (EPA) has moved to ease pollution restrictions on ethylene oxide (EtO), a critical chemical used to sterilize half of all U.S. medical devices. This regulatory shift aims to prevent potential healthcare supply chain disruptions but faces immediate backlash from environmental and public health advocates.
Full story: https://getbiobrief.com/story/epa-weakens-eto-pollution-limits-medical-sterilization

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.